A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts

This publication has 21 references indexed in Scilit:

• A Multi-Institutional Prospective Trial Confirms Noninvasive Blood Test Maintains Predictive Value in African American Men
  Journal of Urology, 2018
• Characteristics of Prostate Cancer Found at Fifth Screening in the European Randomized Study of Screening for Prostate Cancer Rotterdam: Can We Selectively Detect High-grade Prostate Cancer with Upfront Multivariable Risk Stratification and Magnetic Resonance Imaging?
  European Urology, 2018
• An Update of the American Urological Association White Paper on the Prevention and Treatment of the More Common Complications Related to Prostate Biopsy
  Journal of Urology, 2017
• Complications After Systematic, Random, and Image-guided Prostate Biopsy
  European Urology, 2017
• The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
  American Journal of Surgical Pathology, 2016
• Gleason inflation 1998–2011: a registry study of 97 168 men
  BJU International, 2015
• Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer
  Urology, 2014
• Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: results from the prostate biopsy collaborative group
  World Journal of Urology, 2012
• Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group
  World Journal of Urology, 2011
• A graphical device to represent the outcomes of a logistic regression analysis
  The Prostate, 2008